Whither pertussis?
dc.contributor.author | Snelling, Thomas | |
dc.contributor.author | Waddington, C. | |
dc.date.accessioned | 2017-08-24T02:19:53Z | |
dc.date.available | 2017-08-24T02:19:53Z | |
dc.date.created | 2017-08-23T07:21:45Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Snelling, T. and Waddington, C. 2015. Whither pertussis?. Expert Review of Anti-Infective Therapy. 13 (2): pp. 145-148. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/55671 | |
dc.identifier.doi | 10.1586/14787210.2015.986462 | |
dc.description.abstract |
© 2015 Informa UK, Ltd. Several lines of evidence suggest that pertussis disease will continue to rise in countries which have switched to acellular vaccines. While maternal vaccination is promising as a mitigating strategy it is unlikely to replace the need for a better vaccine. In the absence of a clear alternative, a return to using whole cell vaccines, at least in part, should not be dismissed as an option without contemporary studies of feasibility and acceptability. | |
dc.publisher | Expert Reviews Ltd. | |
dc.title | Whither pertussis? | |
dc.type | Journal Article | |
dcterms.source.volume | 13 | |
dcterms.source.number | 2 | |
dcterms.source.startPage | 145 | |
dcterms.source.endPage | 148 | |
dcterms.source.issn | 1478-7210 | |
dcterms.source.title | Expert Review of Anti-Infective Therapy | |
curtin.department | School of Public Health | |
curtin.accessStatus | Open access via publisher |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |